Secondly, we will study the expression levels of CK18 and LEAP-2 in MAFLD related liver fibrosis and cirrhosis to investigate the roles and possible mechanisms of these indicators in the occurrence and progression of MAFLD. Here, LEAP2 is linked to Hepatic fibrosis.